Literature DB >> 9602109

Specific reductions of striatal prodynorphin and D1 dopamine receptor messenger RNAs during cocaine abstinence.

P Svensson1, Y L Hurd.   

Abstract

It is well established that the opioid neuropeptide and dopamine systems are altered following the use of cocaine. However very little information is available about their possible involvement during cocaine abstinence. In the present study, the mRNA expression of the dopamine receptors, D1 and D2, and the opioid peptides, prodynorphin and proenkephalin, were analyzed in the rat striatum using in situ hybridization histochemistry. Saline or cocaine (30 mg/kg, i.p.) were administered to rats once daily for 1 or 10 days. To examine cocaine abstinence, animals were treated for 10 days as described followed by a 10-day drug free period. Acute and intermittent cocaine administration elevated the prodynorphin mRNA expression in the dorsal striatum, consistent with previous reports, while the abstinent phase resulted in a significant reduction of prodynorphin mRNA levels in the ventrorostral striatum. The D1-receptor mRNA was decreased in the caudorostral striatum during cocaine withdrawal, a finding opposite to the increase observed following a single injection of the drug. Proenkephalin and the D2-receptor mRNAs were not altered during cocaine abstinence, though proenkephalin was elevated following acute but not repeated cocaine administration. These results show long-term suppression on prodynorphin and D1-receptor systems in specific striatal populations localized mainly in rostral areas during withdrawal from cocaine. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9602109     DOI: 10.1016/s0169-328x(98)00041-2

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  11 in total

1.  Effects of withdrawal from chronic escalating-dose binge cocaine on conditioned place preference to cocaine and striatal preproenkephalin mRNA in C57BL/6J mice.

Authors:  Yong Zhang; Stefan D Schlussman; Eduardo R Butelman; Ann Ho; Mary Jeanne Kreek
Journal:  Neuropharmacology       Date:  2012-04-04       Impact factor: 5.250

2.  Gender differences in prodynorphin but not proenkephalin mRNA expression in the striatum of adolescent rats exposed to prenatal cocaine.

Authors:  Annelyn Torres-Reveron; Yasmin L Hurd; Diana L Dow-Edwards
Journal:  Neurosci Lett       Date:  2007-05-05       Impact factor: 3.046

Review 3.  The opioid receptors as targets for drug abuse medication.

Authors:  Florence Noble; Magalie Lenoir; Nicolas Marie
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

Review 4.  The endogenous opioid system in cocaine addiction: what lessons have opioid peptide and receptor knockout mice taught us?

Authors:  Ji Hoon Yoo; Ian Kitchen; Alexis Bailey
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

5.  Alcohol dependence, disinhibited behavior and variation in the prodynorphin gene.

Authors:  Janine D Flory; Carolyn L Pytte; Yasmin Hurd; Robert E Ferrell; Stephen B Manuck
Journal:  Biol Psychol       Date:  2011-07-05       Impact factor: 3.251

6.  Cocaine-induced sex differences in D1 dopamine receptor mRNA levels after acute cocaine administration.

Authors:  Eugene D Festa; Kai-Yvonne Shivers; Shirzad Jenab; Vanya Quiñones-Jenab
Journal:  Ethn Dis       Date:  2010       Impact factor: 1.847

7.  Endogenous kappa-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine.

Authors:  John E Pintar; Toni S Shippenberg; Vladimir I Chefer; Traci Czyzyk; Elizabeth A Bolan; Jose Moron
Journal:  J Neurosci       Date:  2005-05-18       Impact factor: 6.167

8.  Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens.

Authors:  Virgina M Pickel; Jane Chan; Christopher S Kearn; Kenneth Mackie
Journal:  J Comp Neurol       Date:  2006-03-20       Impact factor: 3.215

Review 9.  Reward processing by the opioid system in the brain.

Authors:  Julie Le Merrer; Jérôme A J Becker; Katia Befort; Brigitte L Kieffer
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

Review 10.  Dynorphin and the pathophysiology of drug addiction.

Authors:  T S Shippenberg; A Zapata; V I Chefer
Journal:  Pharmacol Ther       Date:  2007-07-24       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.